Chiesi and Gossamer Bio announce transformative global collaboration
Chiesi Group and Gossamer Bio, a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension, today announced that they have entered into a global collaboration and license agreement to develop and commercialize…